CrowdStrike Faces 28 Analyst Confirmations but Drops 6.75% as Stock Slips Below Consensus Target
By TrendSpider Editor
CrowdStrike Holdings, Inc. received ratings confirmations from 28 analyst firms this week, with the average price target coming in at $717.39, yet the stock is trading at $670.56 on Friday, sitting roughly $47 below that consensus figure. The wave of analyst coverage follows what has been an active
CrowdStrike Faces 28 Analyst Confirmations but Drops 6.75% as Stock Slips Below Consensus Target
CrowdStrike Holdings, Inc. received ratings confirmations from 28 analyst firms this week, with the average price target coming in at $717.39, yet the stock is trading at $670.56 on Friday, sitting roughly $47 below that consensus figure. The wave of analyst coverage follows what has been an active stretch for the cybersecurity giant, whose shares are now down 6.75% on the session despite the broadly supportive Wall Street commentary. With a 52-week range of $342.72 to $785.66, CRWD is trading in the upper half of its annual range but has pulled back meaningfully from its yearly highs.
Key Drivers of the CRWD Stock Move
- Main Catalyst: A total of 28 analyst firms confirmed their ratings on CRWD simultaneously, producing zero upgrades and zero downgrades. The bulk of the street remains constructive, with 20 buy-equivalent ratings and 8 hold-equivalent ratings. Price targets ranged widely, from a low of $413 (Bernstein) to a high of $825 (Rosenblatt), with an average of $717.39.
- Bull Case: The sheer breadth of buy confirmations, 20 out of 28 firms, signals durable institutional conviction in CrowdStrike's outlook. Several firms made substantial upward revisions to their price targets, most notably Susquehanna raising its target from $475 to $800, Needham moving from $475 to $780, and D.A. Davidson lifting from $455 to $765. UBS and Stifel both landed at $790, while Rosenblatt set the street-high at $825, all representing meaningful upside from the current price of $670.56.
- Bear Case: Despite the positive tone, the stock is down 6.75% on the session, suggesting the analyst commentary is not enough to offset whatever selling pressure is driving today's move. Several firms maintained hold ratings with targets at or below current trading levels, including Bernstein at $413, BNP Paribas at $520, and Baird at $520. The absence of any upgrades among 28 actions means no new institutional sponsorship was added today.
The forward setup for CRWD is a tug-of-war between strong long-term analyst conviction and near-term price weakness. The stock is sitting approximately 14.6% below its 52-week high of $785.66, and today's selloff has brought shares closer to the lower end of the analyst price target distribution. Firms like Morgan Stanley ($690) and TD Cowen ($700) have targets only modestly above the current price, which narrows the margin of safety for near-term buyers. The sheer volume of analyst activity, 28 firms confirming in a single session, typically accompanies a major earnings report or investor day, suggesting the street is resetting expectations following a significant company event. Whether the fundamental update embedded in these new price targets is enough to stabilize the stock will be the key question heading into next week.
CRWD Analyst Ratings and Price Targets
All 28 analyst actions were confirmations of existing ratings, with no upgrades or downgrades recorded. The consensus leans heavily bullish, with 20 buy ratings and 8 holds. The average price target across all 28 firms is $717.39, implying upside of approximately 7% from the current price of $670.56. Key actions are summarized below:
- Rosenblatt (Catharine Trebnick): Confirms buy | PT raised to $825 from $640
- Susquehanna (Shyam Patil): Confirms buy | PT raised to $800 from $475
- UBS (Roger Boyd): Confirms buy | PT raised to $790 from $525
- Stifel (Adam Borg): Confirms buy | PT raised to $790 from $660
- Needham (Mike Cikos): Confirms buy | PT raised to $780 from $475
- Citigroup (Fatima Boolani): Confirms buy | PT raised to $780 from $525
- Citizens (Rustam Kanga): Confirms buy | PT raised to $780 from $550
- Benchmark (Yi Fu Lee): Confirms buy | PT raised to $780 from $700
- BTIG (Gray Powell): Confirms buy | PT unchanged at $764
- D.A. Davidson (Rudy Kessinger): Confirms buy | PT raised to $765 from $455
- Jefferies (Joseph Gallo): Confirms buy | PT lowered to $760 from $775
- RBC Capital (Matthew Hedberg): Confirms buy | PT raised to $755 from $650
- Bank of America (Tal Liani): Confirms hold | PT raised to $750 from $535
- Piper Sandler (Rob Owens): Confirms buy | PT raised to $750 from $520
- Truist Securities (Junaid Siddiqui): Confirms buy | PT raised to $750 from $650
- BMO Capital (Keith Bachman): Confirms buy | PT raised to $745 from $685
- Wells Fargo (Michael Turrin): Confirms buy | PT raised to $725 from $700
- Cantor Fitzgerald (Jonathan Ruykhaver): Confirms buy | PT raised to $725 from $700
- Wedbush (Dan Ives): Confirms buy | PT raised to $720 from $700
- TD Cowen (Shaul Eyal): Confirms buy | PT raised to $700 from $625
- Mizuho (Gregg Moskowitz): Confirms buy | PT raised to $700 from $630
- Morgan Stanley (Keith Weiss): Confirms buy | PT raised to $690 from $610
- Canaccord Genuity (Kingsley Crane): Confirms hold | PT raised to $675 from $400
- Barclays (Saket Kalia): Confirms buy | PT raised to $675 from $650
- Macquarie (Steve Koenig): Confirms hold | PT raised to $660 from $400
- Baird (Shrenik Kothari): Confirms hold | PT raised to $520 from $490
- BNP Paribas (Andrew DeGasperi): Confirms hold | PT raised to $520 from $400
- Bernstein (Peter Weed): Confirms hold | PT raised to $413 from $368
CRWD Seasonality
Early June marks the period following CrowdStrike's fiscal first quarter earnings, which historically triggers a broad round of analyst target resets. Price action in this window has tended